Repligen Corporation (RGEN) is in Healthcare, Medical Instruments & Supplies, based in United States, listed on NasdaqGS. Market cap 10.40B USD. 52-week range 100.99 to 198.87 USD. Trailing P/E 224.4. Data as of 2026-10-09.
Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution ...